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peptides both in the cytosol/nucleus (where protea-Proteasomes Get By with
somes are located) and in the endoplasmic reticulumLots of Help from Their Friends (ER), following delivery of peptides by the transporter
associated with antigen processing (TAP). ER amino-
peptidases appear to play a particularly important role
in peptide generation (Serwold et al., 2002; York et al.,Proteasomes can’t do it all. It was previously known
2002).that aminopeptidases frequently degrade protea-
For obscure, but no doubt important, reasons cellssome-generated peptides. Now it appears that an-
are devoid of active carboxypeptidases. It has been
other protease, tripeptidyl peptidase II (TPP II), plays
generally accepted that proteasomes must liberate the
a critical role in cleaving proteasomal produced pep-
C termini of class I peptide ligands (Shastri et al., 2002).
tides into shorter peptides that can then be degraded
With the findings of Reits et al., published in this issue
by aminopeptidases.
of Immunity, it now appears that a second large cellular
protease with endopeptidase activity contributes to the
Nature abounds with nasty, selfish things like viruses generation of C-terminal cleavages that produce MHC
and tumor cells bent on their own survival at our ex- class I binding peptides. Most importantly, the authors
pense. Fortunately, for protection our vertebrate ances- provide convincing evidence that this protease, tripepti-
tors endowed us with CD8 T cells and MHC class I dyl peptidase II (TPP II), plays an essential role in gener-
molecules (and NK cells, etc.). CD8 T cells roam our ating many MHC class I peptide ligands.
nooks and crannies, sifting through countless MHC The participation of TPP II in antigen presentation was
class I molecules for the faintest peptidic traces of trou- first implied by the findings of Glas et al. (1998), who
ble. Unless a cell happens to be a professional antigen- reported that a large protease (later identified as TPP II
presenting cell, nearly all of the peptides displayed by by Geier et al. [1999]) could replace the functions of
class I molecules will have been synthesized by the proteasomes in cells adapted to grow in the proteasome
cell’s own ribosomes. Virtually all of these peptides are inhibitor NLVS. Subsequently, however, it was shown
generated from longer polypeptides by the action of that NLVS-resistant cells remained sensitive to all other
proteases. Current evidence suggests that most of pep- proteasome inhibitors tested, raising doubts regarding
tides are derived from the significant fraction of polypep- the functional overlap between TPP II and proteasomes
tides degraded with a half-life of10 min following their (Princiotta et al., 2001). In any event, Geier et al. demon-
synthesis (Yewdell et al., 2003). Presumably these pro- strated that TPP II exhibits endopeptidase activity, sug-
teins are degraded due to some defect that prevents gesting the possibility that it contributes to the many
them from attaining a stable conformation in a reason- independent examples of ongoing antigen presentation
able time frame. in proteasome inhibitor treated cells (Shastri et al., 2002).
This year marks the tenth anniversary of the landmark The proverbial smoking gun was provided by Seifert et
study demonstrating that proteasomes are responsible al. (2003), in demonstrating that generation of a defined
for the vast majority of protein degradation in cells (in- viral peptide required catalytically active TPP II but
cluding degradation of newly synthesized proteins), and not proteasomes.
are involved in the generation of most class I peptide In their present study, Reits et al. place TPP II squarely
ligands (Rock et al., 1994). Class I molecules are finicky in the main stream of class I processing pathways. This
about peptide length; each peptide presented has an group has pioneered the (in their own words) “single
optimal length for high- affinity binding that ranges from cell biochemistry” approach to antigen processing by
8 to 11 residues. It was initially thought that proteasomes creative application of fluorescent molecules and confo-
acted as a “molecular ruler,” generating peptides of cal microscopy. In this installment, they use internally
the proper length for high-affinity class I binding. More quenched fluorescent peptides microinjected into cells
recent studies, however, demonstrated that this was to characterize peptide degradation, which is inferred
the exception rather than the rule(r). Most proteasome- by increased fluorescence that accompanies cleavage
generated peptides require further trimming. It is now between the fluorescent and quencher groups attached
to amino acid side chains. This is an exquisite applica-clear that aminopeptidases trim proteasome- generated
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tion of technology to the experimental problem at hand, change in pAPCs or cells exposed to cytokines that
since it is difficult to imagine approaching the question enhance antigen presentation? Do immunoproteasomes
in any other way. produce shorter peptides less dependent on TPP II
Extending their prior findings on aminopeptidase cleavage? Or do PA28 proteasome regulators, whose
cleavage of peptides in living cells (Reits et al., 2003), role in antigen presentation has remained elusive, play
Reits et al. show that as peptides exceed 15 residues this role? Does TPP II also participate in the generation
the critical role of aminopeptidases in degradation is of peptides from exogenous antigens? If so, does it
usurped by TPP II. TPP II functions as both an aminopep- colocalize with proteasomes and TAP in regions where
tidase and an endopeptidase. Curiously, its endopepti- phagosomes fuse with the ER in pAPCs? And finally the
dase activity requires an unblocked amino terminus, big one: have all of the major proteases involved in the
suggesting that the two activities are linked. The judi- generation of class I peptide ligand been identified, or
cious insertion of D amino acids (which resist proteolytic do other surprises await us?
cleavage), into the polypeptide sequence, demonstrates
that TPP II liberates peptides of 9 or more residues from Jonathan W. Yewdell and Michael F. Princiotta
longer polypeptide chains. To address the involvement Laboratory of Viral Diseases
of TPP II in antigen processing the authors used butabin- National Institute of Allergy and Infectious Diseases
dide, a cell permeable TPP II inhibitor. Cells were treated Bethesda, Maryland 208920
with acid to denature existing cell surface class I mole-
cules, and class I reexpression was measured in the Selected Reading
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on by TPP II, which removes some of the N-terminal
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or is this facilitated in some way? Does TPP II physically York, I.A., Chang, S.C., Saric, T., Keys, J.A., Favreau, J.M., Goldberg,
A.L., and Rock, K.L. (2002). Nat. Immunol. 3, 1177–1184.associate with proteasomes or TAP? Does TPP II’s role
of the TCR/CD3 complex, they share properties withBetting on NKT and NK Cells
“innate lymphocytes” that closely resemble NK cells,
such as the expression of invariant, germline-encoded
receptors (Bendelac et al., 2001). Although the definition
of NKT cells is expanding (Kronenberg and Gapin, 2002),Natural killer T (NKT) cells, as their name implies, consti-
a specific TCR chain (V14/J28) is expressed by mosttutively express markers and receptors first identified on
murine NKT cells and is strikingly conserved betweenbona fide natural killer (NK) cells, supporting a potential
mice and humans. These V14-invariant (V14i) NKTrelationship between NKT and NK cells. In this issue of
Immunity, Townsend et al. further define this relationship cells recognize CD1-restricted antigens, as represented
in terms of the transcription factor, T-bet. by the marine sponge-derived glycolipid, -galactosyl
ceramide (-GalCer). Perhaps the best known function
of NKT cells is related to their unique innate capacityAlthough NKT cells display rearranged T cell antigen
to secrete several cytokines, including IL-4 and inter-receptor (TCR) chains in association with the CD3 com-
plex in distinction from NK cells that lack expression feron- (IFN), very quickly after TCR stimulation in vivo.
